Second generation of temporary implantable nitinol device (iTind) in men with lower urinary tract symptoms (LUTS): Who profit most from treatment? 2 year results of the MT-02-study

• G. Kadner,
• M. Valerio,
• I. Giannakis,
• M. Arya,
• N. Lumen,
• B.S. Ho,
• S. Alonso,
• C. Schulman,
• N. Barber,
• D. Amparore,
• F. Porpigila

Affiliations

G. Kadner

M. Valerio

I. Giannakis

M. Arya

N. Lumen

B.S. Ho

S. Alonso

C. Schulman

N. Barber

D. Amparore

F. Porpigila